Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 77
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for ADMA

Stock Name	ADMA Biologics Inc
Ticker	ADMA(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US0008991046

Show aggregate ADMA holdings

News associated with ADMA

Charles Schwab Investment Management Inc. Raises Position in ADMA Biologics Inc (NASDAQ:ADMA): Charles Schwab Investment Management Inc. boosted its stake in ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 0.9% during the first quarter, HoldingsChannel reports. The institutional investor owned 2,462,005 shares of the biotechnology company’s stock after buying an additional 21,711 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in ADMA Biologics were worth […] - 2025-08-17 06:22:54
PNC Financial Services Group Inc. Increases Stake in ADMA Biologics Inc (NASDAQ:ADMA): PNC Financial Services Group Inc. raised its holdings in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 24.3% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 23,325 shares of the biotechnology company’s stock after acquiring an additional 4,553 shares during the […] - 2025-08-14 04:55:07
Harvest Fund Management Co. Ltd Takes Position in ADMA Biologics Inc (NASDAQ:ADMA): Harvest Fund Management Co. Ltd bought a new stake in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) during the first quarter, Holdings Channel reports. The fund bought 2,611 shares of the biotechnology company’s stock, valued at approximately $52,000. A number of other hedge funds and other institutional investors have also recently made changes […] - 2025-08-01 05:32:51
ADMA Biologics Inc (NASDAQ:ADMA) Shares Acquired by Envestnet Asset Management Inc.: Envestnet Asset Management Inc. boosted its stake in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 14.5% in the first quarter, HoldingsChannel reports. The firm owned 68,686 shares of the biotechnology company’s stock after purchasing an additional 8,682 shares during the quarter. Envestnet Asset Management Inc.’s holdings in ADMA Biologics were worth $1,363,000 […] - 2025-08-01 04:36:52
Skandinaviska Enskilda Banken AB publ Invests $35,000 in ADMA Biologics Inc (NASDAQ:ADMA): Skandinaviska Enskilda Banken AB publ purchased a new position in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) in the first quarter, HoldingsChannel reports. The firm purchased 1,773 shares of the biotechnology company’s stock, valued at approximately $35,000. A number of other hedge funds have also modified their holdings of ADMA. Vanguard Group Inc. […] - 2025-07-31 05:57:11
Avantax Advisory Services Inc. Has $2.15 Million Stake in ADMA Biologics Inc (NASDAQ:ADMA): Avantax Advisory Services Inc. lifted its position in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 1.8% during the 1st quarter, HoldingsChannel reports. The fund owned 108,327 shares of the biotechnology company’s stock after purchasing an additional 1,954 shares during the period. Avantax Advisory Services Inc.’s holdings in ADMA Biologics were worth $2,149,000 […] - 2025-07-31 05:16:47
Cerity Partners LLC Acquires 4,575 Shares of ADMA Biologics Inc (NASDAQ:ADMA): Cerity Partners LLC boosted its holdings in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 10.6% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 47,703 shares of the biotechnology company’s stock after buying an additional 4,575 shares during the quarter. Cerity Partners LLC’s holdings in ADMA Biologics were worth $946,000 as […] - 2025-07-24 04:32:54
ADMA Biologics Inc (NASDAQ:ADMA) Shares Sold by Mutual of America Capital Management LLC: Mutual of America Capital Management LLC lessened its position in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 3.9% during the 1st quarter, Holdings Channel reports. The firm owned 34,423 shares of the biotechnology company’s stock after selling 1,384 shares during the quarter. Mutual of America Capital Management LLC’s holdings in ADMA Biologics […] - 2025-07-22 07:10:54
Bank of New York Mellon Corp Decreases Holdings in ADMA Biologics Inc (NASDAQ:ADMA): Bank of New York Mellon Corp cut its holdings in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 3.5% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,468,609 shares of the biotechnology company’s stock after selling 52,557 shares during the quarter. Bank […] - 2025-07-17 04:42:50
ADMA Biologics Inc (NASDAQ:ADMA) Shares Acquired by Principal Financial Group Inc.: Principal Financial Group Inc. boosted its position in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 2.3% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,288,121 shares of the biotechnology company’s stock after purchasing an additional 29,107 […] - 2025-07-09 05:45:05
Robeco Institutional Asset Management B.V. Boosts Holdings in ADMA Biologics Inc (NASDAQ:ADMA): Robeco Institutional Asset Management B.V. lifted its stake in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 48.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 258,609 shares of the biotechnology company’s stock after buying an additional 84,125 shares during the […] - 2025-07-01 05:25:03
ADMA Biologics Inc (NASDAQ:ADMA) Shares Sold by Illinois Municipal Retirement Fund: Illinois Municipal Retirement Fund decreased its position in ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 17.3% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 105,223 shares of the biotechnology company’s stock after selling 21,937 shares during the period. Illinois Municipal Retirement Fund’s holdings in ADMA […] - 2025-06-30 05:38:52
Moran Wealth Management LLC Invests $795,000 in ADMA Biologics Inc (NASDAQ:ADMA): Moran Wealth Management LLC purchased a new position in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 40,056 shares of the biotechnology company’s stock, valued at approximately $795,000. A number of other large investors […] - 2025-06-27 05:14:54
State of Alaska Department of Revenue Sells 3,365 Shares of ADMA Biologics Inc (NASDAQ:ADMA): State of Alaska Department of Revenue reduced its stake in ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 2.5% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 130,981 shares of the biotechnology company’s stock after selling 3,365 shares during the period. […] - 2025-06-23 04:46:52
ADMA Biologics Inc (NASDAQ:ADMA) Director Sells $3,941,719.76 in Stock: ADMA Biologics Inc (NASDAQ:ADMA – Get Free Report) Director Steve Elms sold 194,749 shares of the business’s stock in a transaction dated Monday, June 16th. The stock was sold at an average price of $20.24, for a total transaction of $3,941,719.76. Following the transaction, the director now owns 87,330 shares in the company, valued at […] - 2025-06-20 05:14:53
Insider Selling: ADMA Biologics Inc (NASDAQ:ADMA) Director Sells 137,931 Shares of Stock: ADMA Biologics Inc (NASDAQ:ADMA – Get Free Report) Director Steve Elms sold 137,931 shares of ADMA Biologics stock in a transaction dated Friday, June 13th. The stock was sold at an average price of $20.82, for a total value of $2,871,723.42. Following the completion of the sale, the director now owns 282,079 shares of the […] - 2025-06-19 05:11:05
ADMA Biologics (NASDAQ:ADMA) Stock Price Down 6.8% on Insider Selling: ADMA Biologics Inc (NASDAQ:ADMA – Get Free Report) shares traded down 6.8% on Tuesday following insider selling activity. The company traded as low as $19.17 and last traded at $19.01. 1,700,847 shares traded hands during trading, a decline of 54% from the average session volume of 3,667,821 shares. The stock had previously closed at $20.40. […] - 2025-06-19 02:13:07
SPYV, SAWS: Big ETF Inflows: Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel, the biggest inflow was seen in the SPDR Portfolio S&P 500 Value ETF, which added 14,400,000 units, or a 2.8% increase week over week. Among the largest underlying components of - 2025-06-11 13:09:49
Rhumbline Advisers Buys 1,088 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA): Rhumbline Advisers raised its stake in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 0.2% in the 1st quarter, Holdings Channel reports. The firm owned 622,167 shares of the biotechnology company’s stock after purchasing an additional 1,088 shares during the quarter. Rhumbline Advisers’ holdings in ADMA Biologics were worth $12,344,000 at the end […] - 2025-06-09 05:26:49
Wellington Management Group LLP Sells 13,834 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA): Wellington Management Group LLP lessened its holdings in ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 11.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 105,459 shares of the biotechnology company’s stock after selling 13,834 shares during the quarter. Wellington Management Group […] - 2025-06-06 05:04:51
California State Teachers Retirement System Acquires 8,717 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA): California State Teachers Retirement System grew its position in ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 4.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 217,391 shares of the biotechnology company’s stock after purchasing an additional 8,717 […] - 2025-06-05 05:33:03
B. Riley Wealth Advisors Inc. Cuts Stake in ADMA Biologics, Inc. (NASDAQ:ADMA): B. Riley Wealth Advisors Inc. lowered its position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 31.8% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 12,614 shares of the biotechnology company’s stock after selling 5,892 shares during the period. B. Riley Wealth Advisors Inc.’s holdings in ADMA Biologics were worth […] - 2025-06-02 05:40:55
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $8.77 Million Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA): UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 0.3% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 511,526 shares of the biotechnology company’s stock after acquiring an additional 1,559 shares during […] - 2025-06-01 05:37:02
ADMA Biologics, Inc. (NASDAQ:ADMA) Shares Sold by Tidal Investments LLC: Tidal Investments LLC lessened its position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 20.8% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 30,351 shares of the biotechnology company’s stock after selling 7,983 shares during the quarter. Tidal Investments LLC’s holdings […] - 2025-05-29 05:10:54
Janus Henderson Group PLC Acquires 15,000 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA): Janus Henderson Group PLC raised its holdings in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 16.3% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 107,161 shares of the biotechnology company’s stock after purchasing an additional 15,000 shares during the period. Janus Henderson Group PLC’s […] - 2025-05-22 06:14:47
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $2.56 Million Position in ADMA Biologics, Inc. (NASDAQ:ADMA): MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 7.2% during the 4th quarter, Holdings Channel reports. The firm owned 148,638 shares of the biotechnology company’s stock after purchasing an additional 10,047 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.’s holdings in […] - 2025-05-21 06:14:52
ADMA Biologics (NASDAQ:ADMA) Cut to Sell at StockNews.com: StockNews.com downgraded shares of ADMA Biologics (NASDAQ:ADMA – Free Report) from a hold rating to a sell rating in a research report released on Friday morning. Other equities analysts have also issued reports about the stock. Raymond James boosted their price objective on shares of ADMA Biologics from $25.00 to $32.00 and gave the stock […] - 2025-05-12 02:52:44
33,419 Shares in ADMA Biologics, Inc. (NASDAQ:ADMA) Bought by Mariner LLC: Mariner LLC acquired a new stake in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 33,419 shares of the biotechnology company’s stock, valued at approximately $573,000. A number of other hedge funds have also added to […] - 2025-05-01 05:55:00
Analysts Anticipate EZM Will Reach $74: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-04-09 07:49:44
Vanguard Group Inc. Boosts Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA): Vanguard Group Inc. increased its position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 0.4% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 18,198,796 shares of the biotechnology company’s stock after buying an additional 80,302 shares during the quarter. Vanguard […] - 2025-04-04 05:04:57

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) ADMA holdings

Date	Number of ADMA Shares Held	Base Market Value of ADMA Shares	Local Market Value of ADMA Shares	Change in ADMA Shares Held	Change in ADMA Base Value	Current Price per ADMA Share Held	Previous Price per ADMA Share Held
2025-11-11 (Tuesday)	155,542	USD 2,493,338	USD 2,493,338	0	USD 205,315	USD 16.03	USD 14.71
2025-11-10 (Monday)	155,542	USD 2,288,023	USD 2,288,023	398	USD 35,332	USD 14.71	USD 14.52
2025-11-07 (Friday)	155,144	USD 2,252,691	USD 2,252,691	0	USD 76,021	USD 14.52	USD 14.03
2025-11-06 (Thursday)	155,144	USD 2,176,670	USD 2,176,670	398	USD -201,776	USD 14.03	USD 15.37
2025-11-05 (Wednesday)	154,746	USD 2,378,446	USD 2,378,446	0	USD 114,512	USD 15.37	USD 14.63
2025-11-04 (Tuesday)	154,746	USD 2,263,934	USD 2,263,934	400	USD -108,364	USD 14.63	USD 15.37
2025-11-03 (Monday)	154,346	USD 2,372,298	USD 2,372,298	0	USD -16,978	USD 15.37	USD 15.48
2025-10-31 (Friday)	154,346	USD 2,389,276	USD 2,389,276	0	USD 32,413	USD 15.48	USD 15.27
2025-10-30 (Thursday)	154,346	USD 2,356,863	USD 2,356,863	2,000	USD -9,070	USD 15.27	USD 15.53
2025-10-29 (Wednesday)	152,346	USD 2,365,933	USD 2,365,933	800	USD 6,362	USD 15.53	USD 15.57
2025-10-28 (Tuesday)	151,546	USD 2,359,571	USD 2,359,571	0	USD -4,547	USD 15.57	USD 15.6
2025-10-27 (Monday)	151,546	USD 2,364,118	USD 2,364,118	0	USD 63,650	USD 15.6	USD 15.18

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of ADMA by Blackrock for IE00BDZVHG35

Show aggregate share trades of ADMA

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-10 BUY 398 14.793 14.180 14.241 USD 5,668 18.40
2025-11-06 BUY 398 15.240 13.830 13.971 USD 5,560 18.45
2025-11-04 BUY 400 15.560 14.620 14.714 USD 5,886 18.48
2025-10-30 BUY 2,000 15.760 15.255 15.306 USD 30,611 18.54
2025-10-29 BUY 800 15.530 15.750 15.728 USD 12,582 18.55
2025-10-22 SELL -1,596 15.160 15.450 15.421 USD -24,612 18.64 Profit of 5,145 on sale
2025-10-20 BUY 798 14.690 14.800 14.789 USD 11,802 18.69
2025-10-17 BUY 1,993 14.360 14.600 14.576 USD 29,050 18.72
2025-10-15 BUY 3,176 15.090 15.600 15.549 USD 49,384 18.74
2025-10-03 BUY 2,758 14.660 14.890 14.867 USD 41,003 18.78
2025-10-02 BUY 394 14.530 15.000 14.953 USD 5,891 18.81
2025-09-30 BUY 786 14.660 14.920 14.894 USD 11,707 18.86
2025-09-26 BUY 786 15.610 15.630 15.628 USD 12,284 18.90
2025-09-25 BUY 786 15.320 15.540 15.518 USD 12,197 18.93
2025-09-18 BUY 413 16.160 16.170 16.169 USD 6,678 18.94
2025-09-17 BUY 1,245 15.560 15.960 15.920 USD 19,820 18.97
2025-07-17 SELL -826 17.590 18.220 18.157 USD -14,998 19.02 Profit of 714 on sale
2025-07-16 BUY 1,484 17.690 18.262 18.205 USD 27,016 19.03
2025-07-11 SELL -3,272 18.510 18.665 18.650 USD -61,021 19.04 Profit of 1,287 on sale
2025-07-02 BUY 22,495 18.140 18.190 18.185 USD 409,072 19.06
2025-06-25 BUY 818 17.600 17.880 17.852 USD 14,603 19.09
2025-06-20 BUY 4,577 17.740 18.193 18.148 USD 83,062 19.12
2025-06-11 BUY 786 21.870 22.370 22.320 USD 17,544 19.07
2025-06-10 BUY 786 20.860 21.390 21.337 USD 16,771 19.06
2025-06-04 SELL -394 20.330 20.790 20.744 USD -8,173 19.02 Loss of -681 on sale
2025-04-23 BUY 393 21.730 22.730 22.630 USD 8,894 18.34
2025-04-10 SELL -3,144 18.680 19.190 19.139 USD -60,173 18.10 Loss of -3,269 on sale
2025-04-08 SELL -393 17.860 19.490 19.327 USD -7,596 18.09 Loss of -487 on sale
2025-04-07 SELL -393 18.400 18.890 18.841 USD -7,405 18.08 Loss of -298 on sale
2025-04-04 SELL -1,965 18.010 19.000 18.901 USD -37,140 18.08 Loss of -1,604 on sale
2025-04-01 BUY 3,442 19.420 19.910 19.861 USD 68,362 18.04
2025-03-31 SELL -1,161 19.840 19.910 19.903 USD -23,107 18.02 Loss of -2,185 on sale
2025-03-21 BUY 5,056 19.800 19.820 19.818 USD 100,200 17.86
2025-03-14 SELL -5,936 18.430 18.570 18.556 USD -110,148 17.76 Loss of -4,718 on sale
2025-03-07 SELL -742 17.020 17.270 17.245 USD -12,796 17.78 Profit of 399 on sale
2025-03-04 SELL -371 17.010 17.075 17.069 USD -6,332 17.81 Profit of 275 on sale
2025-02-25 BUY 744 15.440 15.770 15.737 USD 11,708 17.99
2025-02-19 SELL -371 16.070 16.670 16.610 USD -6,162 18.14 Profit of 568 on sale
2025-02-13 BUY 1,113 16.080 16.150 16.143 USD 17,967 18.31
2025-02-12 BUY 371 15.840 15.870 15.867 USD 5,887 18.36
2025-02-11 BUY 1,484 15.880 16.855 16.757 USD 24,868 18.41
2024-12-30 SELL -12,147 17.490 17.530 17.526 USD -212,888 19.22 Profit of 20,575 on sale
2024-11-18 SELL -6,045 19.540 19.588 19.583 USD -118,380 17.89 Loss of -10,228 on sale
2024-11-08 SELL -403 22.620 23.520 23.430 USD -9,442 17.28 Loss of -2,480 on sale
2024-10-21 SELL -404 15.620 15.960 15.926 USD -6,434 0.00 Loss of -6,434 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-10	BUY	398	14.793	14.180	14.241	USD 5,668	18.40
2025-11-06	BUY	398	15.240	13.830	13.971	USD 5,560	18.45
2025-11-04	BUY	400	15.560	14.620	14.714	USD 5,886	18.48
2025-10-30	BUY	2,000	15.760	15.255	15.306	USD 30,611	18.54
2025-10-29	BUY	800	15.530	15.750	15.728	USD 12,582	18.55
2025-10-22	SELL	-1,596	15.160	15.450	15.421	USD -24,612	18.64 Profit of 5,145 on sale
2025-10-20	BUY	798	14.690	14.800	14.789	USD 11,802	18.69
2025-10-17	BUY	1,993	14.360	14.600	14.576	USD 29,050	18.72
2025-10-15	BUY	3,176	15.090	15.600	15.549	USD 49,384	18.74
2025-10-03	BUY	2,758	14.660	14.890	14.867	USD 41,003	18.78
2025-10-02	BUY	394	14.530	15.000	14.953	USD 5,891	18.81
2025-09-30	BUY	786	14.660	14.920	14.894	USD 11,707	18.86
2025-09-26	BUY	786	15.610	15.630	15.628	USD 12,284	18.90
2025-09-25	BUY	786	15.320	15.540	15.518	USD 12,197	18.93
2025-09-18	BUY	413	16.160	16.170	16.169	USD 6,678	18.94
2025-09-17	BUY	1,245	15.560	15.960	15.920	USD 19,820	18.97
2025-07-17	SELL	-826	17.590	18.220	18.157	USD -14,998	19.02 Profit of 714 on sale
2025-07-16	BUY	1,484	17.690	18.262	18.205	USD 27,016	19.03
2025-07-11	SELL	-3,272	18.510	18.665	18.650	USD -61,021	19.04 Profit of 1,287 on sale
2025-07-02	BUY	22,495	18.140	18.190	18.185	USD 409,072	19.06
2025-06-25	BUY	818	17.600	17.880	17.852	USD 14,603	19.09
2025-06-20	BUY	4,577	17.740	18.193	18.148	USD 83,062	19.12
2025-06-11	BUY	786	21.870	22.370	22.320	USD 17,544	19.07
2025-06-10	BUY	786	20.860	21.390	21.337	USD 16,771	19.06
2025-06-04	SELL	-394	20.330	20.790	20.744	USD -8,173	19.02 Loss of -681 on sale
2025-04-23	BUY	393	21.730	22.730	22.630	USD 8,894	18.34
2025-04-10	SELL	-3,144	18.680	19.190	19.139	USD -60,173	18.10 Loss of -3,269 on sale
2025-04-08	SELL	-393	17.860	19.490	19.327	USD -7,596	18.09 Loss of -487 on sale
2025-04-07	SELL	-393	18.400	18.890	18.841	USD -7,405	18.08 Loss of -298 on sale
2025-04-04	SELL	-1,965	18.010	19.000	18.901	USD -37,140	18.08 Loss of -1,604 on sale
2025-04-01	BUY	3,442	19.420	19.910	19.861	USD 68,362	18.04
2025-03-31	SELL	-1,161	19.840	19.910	19.903	USD -23,107	18.02 Loss of -2,185 on sale
2025-03-21	BUY	5,056	19.800	19.820	19.818	USD 100,200	17.86
2025-03-14	SELL	-5,936	18.430	18.570	18.556	USD -110,148	17.76 Loss of -4,718 on sale
2025-03-07	SELL	-742	17.020	17.270	17.245	USD -12,796	17.78 Profit of 399 on sale
2025-03-04	SELL	-371	17.010	17.075	17.069	USD -6,332	17.81 Profit of 275 on sale
2025-02-25	BUY	744	15.440	15.770	15.737	USD 11,708	17.99
2025-02-19	SELL	-371	16.070	16.670	16.610	USD -6,162	18.14 Profit of 568 on sale
2025-02-13	BUY	1,113	16.080	16.150	16.143	USD 17,967	18.31
2025-02-12	BUY	371	15.840	15.870	15.867	USD 5,887	18.36
2025-02-11	BUY	1,484	15.880	16.855	16.757	USD 24,868	18.41
2024-12-30	SELL	-12,147	17.490	17.530	17.526	USD -212,888	19.22 Profit of 20,575 on sale
2024-11-18	SELL	-6,045	19.540	19.588	19.583	USD -118,380	17.89 Loss of -10,228 on sale
2024-11-08	SELL	-403	22.620	23.520	23.430	USD -9,442	17.28 Loss of -2,480 on sale
2024-10-21	SELL	-404	15.620	15.960	15.926	USD -6,434	0.00 Loss of -6,434 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ADMA

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	554,413	737	1,447,505	38.3%
2025-09-18	435,181	10,124	1,445,628	30.1%
2025-09-17	543,908	2,280	876,530	62.1%
2025-09-16	737,803	539	1,354,532	54.5%
2025-09-15	675,632	2,599	1,376,964	49.1%
2025-09-12	712,792	898	1,337,204	53.3%
2025-09-11	245,175	51	674,953	36.3%
2025-09-10	472,172	2,282	1,124,270	42.0%
2025-09-09	884,089	1,100	1,519,252	58.2%
2025-09-08	766,409	1,658	1,629,503	47.0%
2025-09-05	645,121	53	1,156,332	55.8%
2025-09-04	900,160	6,750	2,273,752	39.6%
2025-09-03	1,231,947	1,355	2,927,053	42.1%
2025-09-02	810,257	1,236	2,109,450	38.4%
2025-08-29	303,289	6,797	702,329	43.2%
2025-08-28	274,561	1,158	997,208	27.5%
2025-08-27	503,270	954	1,369,101	36.8%
2025-08-26	256,012	0	578,123	44.3%
2025-08-25	513,545	2,143	940,749	54.6%
2025-08-22	377,885	799	825,861	45.8%
2025-08-21	199,294	182	788,296	25.3%
2025-08-20	360,602	1,094	570,043	63.3%
2025-08-19	453,129	411	860,623	52.7%
2025-08-18	528,897	4,279	1,092,008	48.4%
2025-08-15	578,165	267	914,924	63.2%
2025-08-14	587,513	1,054	927,272	63.4%
2025-08-13	567,780	462	1,138,209	49.9%
2025-08-12	674,254	0	2,086,060	32.3%
2025-08-11	1,452,382	300	3,031,830	47.9%
2025-08-08	810,291	45,406	1,626,478	49.8%
2025-08-07	3,063,753	85,414	5,058,742	60.6%
2025-08-06	655,276	128	1,327,472	49.4%
2025-08-05	428,337	955	888,079	48.2%
2025-08-04	446,905	400	948,770	47.1%
2025-08-01	502,020	917	776,356	64.7%
2025-07-31	398,016	208	690,219	57.7%
2025-07-30	628,331	1,909	1,119,597	56.1%
2025-07-29	559,011	1,732	873,518	64.0%
2025-07-28	537,514	318	921,685	58.3%
2025-07-25	495,317	480	1,415,367	35.0%
2025-07-24	389,617	1,948	699,976	55.7%
2025-07-23	383,783	4,230	1,967,701	19.5%
2025-07-22	363,559	3,539	788,351	46.1%
2025-07-21	437,901	4,001	781,019	56.1%
2025-07-18	518,685	5,237	1,840,212	28.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE